As with anything in life, our individual preferences and circumstances will vary. Some may want to ‘age in place,’ while others may need to consider ...
The FDA has approved brexpiprazole (Rexulti) opens in a new tab or window for agitation associated with Alzheimer's disease dementia, the agency announced on Thursday.
Without proper planning, the individual with dementia and their family may struggle to cover the costs associated with their care and may face financial stress ...